Swiss National Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-71,200
| Closed | -$1.12M | – | 2530 |
|
|
2024
Q1 | $1.12M | Buy |
71,200
+1,300
| +2% | +$20K | ﹤0.01% | 2158 |
|
|
2023
Q4 | $1.13M | Sell |
69,900
-16,500
| -19% | -$210K | ﹤0.01% | 2174 |
|
|
2023
Q3 | $1.1M | Sell |
86,400
-20,300
| -19% | -$280K | ﹤0.01% | 2195 |
|
|
2023
Q2 | $1.5M | Sell |
106,700
-6,000
| -5% | -$85.8K | ﹤0.01% | 2072 |
|
|
2023
Q1 | $1.74M | Buy |
112,700
+15,900
| +16% | +$265K | ﹤0.01% | 1921 |
|
|
2022
Q4 | $1.59M | Buy |
96,800
+2,600
| +3% | +$42.3K | ﹤0.01% | 2049 |
|
|
2022
Q3 | $1.74M | Buy |
94,200
+11,400
| +14% | +$179K | ﹤0.01% | 1964 |
|
|
2022
Q2 | $1.09M | Sell |
82,800
-14,000
| -14% | -$155K | ﹤0.01% | 2311 |
|
|
2022
Q1 | $897K | Buy |
96,800
+7,200
| +8% | +$61.2K | ﹤0.01% | 2459 |
|
|
2021
Q4 | $875K | Hold |
89,600
| – | – | ﹤0.01% | 2523 |
|
|
2021
Q3 | $3.04M | Buy |
89,600
+700
| +0.8% | +$22.3K | ﹤0.01% | 1774 |
|
|
2021
Q2 | $3.25M | Buy |
88,900
+4,300
| +5% | +$166K | ﹤0.01% | 1789 |
|
|
2021
Q1 | $3.79M | Buy |
84,600
+1,700
| +2% | +$79.2K | ﹤0.01% | 1627 |
|
|
2020
Q4 | $4.73M | Buy |
82,900
+600
| +0.7% | +$35.6K | ﹤0.01% | 1404 |
|
|
2020
Q3 | $4.22M | Buy |
82,300
+3,600
| +5% | +$176K | ﹤0.01% | 1281 |
|
|
2020
Q2 | $4.7M | Buy |
78,700
+29,200
| +59% | +$1.56M | ﹤0.01% | 1182 |
|
|
2020
Q1 | $2.04M | Buy |
49,500
+2,600
| +6% | +$144K | ﹤0.01% | 1447 |
|
|
2019
Q4 | $2.92M | Buy |
46,900
+1,200
| +3% | +$57K | ﹤0.01% | 1501 |
|
|
2019
Q3 | $1.55M | Buy |
45,700
+21,100
| +86% | +$625K | ﹤0.01% | 1807 |
|
|
2019
Q2 | $555K | Sell |
24,600
-2,800
| -10% | -$65.5K | ﹤0.01% | 2387 |
|
|
2019
Q1 | $636K | Buy |
27,400
+800
| +3% | +$20.9K | ﹤0.01% | 2292 |
|
|
2018
Q4 | $558K | Buy |
26,600
+900
| +4% | +$22.1K | ﹤0.01% | 2322 |
|
|
2018
Q3 | $995K | Hold |
25,700
| – | – | ﹤0.01% | 2142 |
|
|
2018
Q2 | $1.01M | Buy |
+25,700
| New | +$756K | ﹤0.01% | 2155 |
|
Other funds holding DCPH
Swiss National Bank's DCPH Position: Q2 2024 in Review
Swiss National Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 71,200 shares — an estimated $1.12M sold.
Swiss National Bank first reported a position in DCPH in Q2 2018 and held it in 24 quarters. The position peaked at $4.73M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Swiss National Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Swiss National Bank sold 71,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.12M.
- Swiss National Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 24 quarters.
- Swiss National Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.73M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.